Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$875.4M
+12.6% from 2023
Prescriptions
37K
$23,577.29 per claim
Patients
8,447
5,892 prescribers
Total spending, 2024
$875.6M
$103,626.38 per patient
Medicare prescription drug plans paid $875.4M for Lenvima in 2024, for 37,130 prescriptions and refills to 8,447 patients (up 12.6% from 2023). The average cost per claim was $23,577.29.
California had the highest Medicare cost for Lenvima in 2024: $103.8M for 4,571 claims, followed by Texas ($80.5M).
Marcia S Brose, medical oncology in Philadelphia, PA, had the highest Medicare cost for Lenvima in 2024: 210 claims costing $5.1M.
Lenvima is made by Eisai Co., Ltd. (4523.T), listed in the Medicare spending data as Eisai Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Marcia S Brose Philadelphia, PA | Medical Oncology | 210 | 25 | $5.1M |
| Arnab Basu Jacksonville, FL | Hematology-Oncology | 121 | 26 | $2.8M |
| Martin H Voss New York, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,953 | 28,318 | 7,064 | $625.9M |
| 2023 | 5,427 | 32,459 | 7,886 | $777.6M |
| 2024 | 5,892 | 37,130 | 8,447 | $875.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 102 |
| 20 |
| $2.3M |
| Monika Joshi Hershey, PA | Hematology-Oncology | 95 | 12 | $2.1M |
| Asim Amin Charlotte, NC | Medical Oncology | 79 | 12 | $1.9M |
| Nizar M Tannir Houston, TX | Medical Oncology | 78 | 14 | $1.8M |
| Zita D Lim Houston, TX | Physician Assistant | 68 | 14 | $1.7M |
| Maria E Cabanillas Houston, TX | Endocrinology | 68 | 15 | $1.6M |
| Julie H Rowe Houston, TX | Hematology-Oncology | 61 | 12 | $1.5M |
| Eric Jonasch Houston, TX | Medical Oncology | 61 | 12 | $1.5M |
| Amishi Y Shah Houston, TX | Medical Oncology | 59 | 11 | $1.4M |
| Putao Cen Houston, TX | Medical Oncology | 61 | 11 | $1.4M |
| Mohsen Ghadimi-Mahani Laredo, TX | Hematology-Oncology | 50 | Under 11 | $1.4M |
| Moshe C Ornstein Cleveland, OH | Hematology-Oncology | 51 | 11 | $1.4M |
| Douglas E Laux Iowa City, IA | Medical Oncology | 60 | Under 11 | $1.4M |
| Jennifer Hernandez New Hyde Park, NY | Physician Assistant | 57 | 15 | $1.4M |
| Maria Carlo New York, NY | Internal Medicine | 58 | Under 11 | $1.3M |
| Julia K Majovski Seattle, WA | Nurse Practitioner | 55 | 11 | $1.3M |
| Hari A Deshpande New Haven, CT | Medical Oncology | 58 | Under 11 | $1.3M |
| Dong M Shin Atlanta, GA | Medical Oncology | 52 | Under 11 | $1.2M |
| James Harding New York, NY | Medical Oncology | 51 | Under 11 | $1.2M |
| Lori J Wirth Boston, MA | Medical Oncology | 51 | 14 | $1.2M |
| Reena Salgia Detroit, MI | Gastroenterology | 50 | Under 11 | $1.2M |
| David Hsieh Dallas, TX | Medical Oncology | 51 | 15 | $1.2M |
| Robert S Alter Hackensack, NJ | Hematology-Oncology | 49 | Under 11 | $1.2M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eisai Inc. 4523.T | 37,139 | $875.6M |